icon-    folder.gif   Conference Reports for NATAP  
 
  22nd Conference on Retroviruses and
Opportunistic Infections
Seattle Washington Feb 23 - 26, 2015
Back grey_arrow_rt.gif
 
 
 
Safety of Tenofovir Alafenamide in Renal Impairment
 
 
  Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
 
Anton Pozniak,1 Jose Arribas,2 Samir K. Gupta,3 Frank A. Post,4 Anchalee Avihingsanon,5 Gordon Crofoot,6 Kenneth Lichtenstein,7 Moti Ramgopal,8 Ploenchan Chetchotisakd,9 Marshall W. Fordyce10
 
1Chelsea and Westminster Hospital NHS Foundation Trust, London, UK; 2Hospital Universitario La Paz, Madrid, Spain; 3Indiana University School of Medicine, Indianapolis, IN; 4King's College Hospital NHS Foundation Trust, London, UK; 5HIV-NAT, Thai Red Cross AIDS Research Center and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 6Crofoot Research, Houston, TX; 7National Jewish Health, Denver, CO; 8Midway Research Center, Ft. Pierce, FL; 9Khon Kaen University, Khon Kaen, Thailand; 10Gilead Sciences, Inc., Foster City, CA

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif

CROI8.gif

CROI9.gif

CROI10.gif

CROI11.gif